Skip to main content
Figure 4 | Biomarker Research

Figure 4

From: Enhanced expression of a 35 kDa fragment of inter-alpha-trypsin inhibitor H4 in sera of healthy pregnant women and patients with hydatidiform mole

Figure 4

Relative expression of ITIH4 fragment in serum samples. Fold-differences calculated for healthy pregnant women (NP) and those with hydatidiform mole (HM) are values relative to the expression of ITIH4 fragment in the control subjects. Values for patients with breast cancer (BrCa), endometrial cancer (EACa), epithelial ovarian cancer (EOCa) and germ-line ovarian cancer (GOCa) were those that had been previously reported [9, 10].

Back to article page